This cross-sectional study aimed to assess the prevalence of dizziness/vertigo inindividuals following COVID-19 and to investigate potential risk factors associated withthese symptoms. A total of 296 patients aged 20-66 years who had recovered from COVID-19were evaluated at Istanbul Physical Medicine and Rehabilitation Training and ResearchHospital between June 1, 2021, and December 31, 2021. Clinical and demographic data,including COVID-19 history, comorbidities, and symptom characteristics, were collected.Dizziness-related disability was assessed using the Dizziness Handicap Inventory (DHI),while balance performance was evaluated with the Berg Balance Scale (BBS).
Not Provided
Inclusion Criteria:
- Individuals aged 20-66 years.
- History of confirmed COVID-19 infection.
- Ability to speak and understand Turkish.
- Willingness to provide verbal and written informed consent.
Exclusion Criteria:
- Pre-existing vertigo or balance disorders (e.g., benign paroxysmal positional
vertigo, Ménière's disease, vestibular migraine, vestibular neuritis).
- Inner ear diseases or vestibular dysfunction.
- Neurological disorders affecting balance (e.g., multiple sclerosis, Parkinson's
disease, history of stroke, epilepsy).
- Psychiatric conditions that could cause dizziness (e.g., anxiety, panic attacks,
depression).
- History of head or neck trauma in the past six months.
- Moderate to severe visual impairment.
- Chronic alcohol or substance use.
- Use of ototoxic medications.
- Severe cardiovascular diseases (e.g., orthostatic hypotension, advanced heart
failure, severe arrhythmias).
- Pregnant or breastfeeding women.
- Acute infection other than COVID-19 in the past three months.
- Severe COVID-19 requiring hospitalization
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Istanbul 745044, Turkey (Türkiye)
Not Provided